Summary of GLP-1 Autoinjector and Medical Device Labeling Capabilities: Medium to high-speed labeling applications Label reconciliation & assurance labeling, never putting a bad label on a good product and eliminating the need for reworking unlabeled products Eliminating the need for pucks, no change parts required Proven, validated device labeling solutions Integration of RFID along with variable data printing and inspection Product inspection as well as label inspection Providing labeling solutions that meet market demands For More ProMach Pharma News, click here
The compound has been studied in models of traumatic brain injury, peripheral nerve damage, neurotoxicity, and mood disorders producing results that have surprised many researchers given the peptides gastrointestinal origins
Central Nervous System Research Models An emerging area of BPC-157 research involves selected preclinical rodent central nervous system injury models and brain-gut-axis-related hypotheses
Pan H-C, Chen J-Y, Chen H-Y, Yeh F-Y, Sun C-Y, Huang TT-M, et al
The average molecular weight of AMG 133 is 153,514 Da and the peptide sequence including the linker is H[Aib]EGTFTSDYSSYLEEQAAKEFIAWLVKGGG(GGGGS)3K(BrAc) 20